Ellevest, Inc. Ocugen, Inc. Transaction History

Ellevest, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	SELL	$1.75 - $3.1 $43 - $77	-25 Reduced 15.82%	133 $0
Q2 2022 Jul 18, 2022	BUY	$1.83 - $3.45 $107 - $203	59 Added 59.6%	158 $0
Q1 2022 Apr 19, 2022	BUY	$2.34 - $4.72 $135 - $273	58 Added 141.46%	99 $0
Q4 2021 Jan 24, 2022	SELL	$4.38 - $15.67 $21 - $78	-5 Reduced 10.87%	41 $0
Q3 2021 Oct 19, 2021	BUY	$6.36 - $8.51 $292 - $391	46 New	46 $0

123

78.3M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $169M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.